AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8200
-0.0600 (-6.82%)
At close: May 13, 2026, 4:00 PM EDT
0.8017
-0.0183 (-2.23%)
After-hours: May 13, 2026, 8:00 PM EDT
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
21.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Celularity | 26.55M |
| Curis | 9.44M |
| Marker Therapeutics | 3.55M |
| Longeveron | 1.20M |
| ABVC BioPharma | 797.92K |
| VYNE Therapeutics | 570.00K |
| Exicure | 500.00K |
| Allarity Therapeutics | 320.00K |
AEON News
- 19 days ago - AEON Biopharma Sets Annual Shareholder Meeting - GlobeNewsWire
- 5 weeks ago - Aeon receives additional notice related to NYSE American listing standards - TheFly
- 5 weeks ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 5 weeks ago - AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards - GlobeNewsWire
- 6 weeks ago - AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program - GlobeNewsWire
- 7 weeks ago - Aeon Biopharma announces FDA feedback after Type 2a meeting - TheFly
- 2 months ago - Aeon Biopharma appoints John Bencich as CFO - TheFly
- 3 months ago - Aeon Biopharma files to sell 51.29M shares of Class A common stock for holders - TheFly